Prognostic Factors for CMV Reactivation/Infection after Stem Cell Transplantation and Value of Oral Valganciclovir for Preemptive Therapy.
| Autor: | Graef, Thorsten *, Bobrikova, Tatjana *, Adams, Ortwin *, Fenk, Roland *, Ruf, Leilani *, Zohren, Fabian *, Gattermann, Norbert, Haas, Rainer *, Kobbe, Guido * |
|---|---|
| Zdroj: | In Blood 16 November 2005 106(11):5369-5369 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|